REGULATORY IMPLICATIONS - A COMPANY PERSPECTIVE

被引：2

作者：

MACDONALD, CM

机构：

来源：

关键词：

D O I：

10.1042/bst0190467

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：467 / 468

页数：2

共 50 条

[21] Regulatory perspective
Anon
[J]. Water Environment and Technology, 2002, 14 (04):
[22] An FDA Perspective on the Regulatory Implications of Complex Signatures to Predict Response to Targeted Therapies
Beaver, Julia A.
Tzou, Abraham
Blumenthal, Gideon M.
Mckee, Amy E.
Kim, Geoffrey
Pazdur, Richard
Philip, Reena
[J]. CLINICAL CANCER RESEARCH, 2017, 23 (06) : 1368 - 1372
[23] COMPANY CONTROLLERS, COMPANY CHECKS AND THEFT - AN AUSTRALIAN PERSPECTIVE
VONNESSEN, P
[J]. CRIMINAL LAW REVIEW, 1986, : 154 - 161
[24] Regulatory competition in European company law
Amit M. Sachdeva
[J]. European Journal of Law and Economics, 2010, 30 : 137 - 170
[25] Regulatory competition in European company law
Sachdeva, Amit M.
[J]. EUROPEAN JOURNAL OF LAW AND ECONOMICS, 2010, 30 (02) : 137 - 170
[26] The Large Pharmaceutical Company Perspective
Rosenblatt, Michael
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (01): : 52 - 60
[27] AN INSURANCE COMPANY PERSPECTIVE ON SMOKING
COWELL, MJ
[J]. NEW YORK STATE JOURNAL OF MEDICINE, 1985, 85 (07) : 307 - 309
[28] PERSPECTIVE - REGULATORY ENFORCEMENT
LITTLEFIELD, L
[J]. ASSOCIATION OF FOOD & DRUG OFFICIALS QUARTERLY BULLETIN, 1978, 42 (03): : 211 - 214
[29] Pharmacogenetics: a regulatory perspective
Suvarna, R.
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 : A75 - A75
[30] Subsidence: A regulatory perspective
Barkley, D
[J]. PRIME FARMLAND INTERACTIVE FORUM, PROCEEDINGS OF, 1998, : 136 - 142